|
EconStor >
Universität Duisburg-Essen (UDE) >
Institute of East Asian Studies IN-EAST, Campus Duisburg, Universität Duisburg-Essen >
Duisburger Arbeitspapiere Ostasienwissenschaften, Universität Duisburg-Essen >
Please use this identifier to cite or link to this item:
http://hdl.handle.net/10419/45003
|
| | |
| Title: | | Health biotechnology in China: National, regional, and sectoral dimensions  |
| Authors: | | Conlé, Marcus |
| Issue Date: | | 2010 |
| Series/Report no.: | | Duisburger Arbeitspapiere Ostasienwissenschaften 87/2010 |
| Abstract: | | Biotechnology is one of the knowledge fields particularly targeted by China, as it is considered to open up windows of opportunity for catch-up to the leading economies. However, the seizing of these opportunities requires the existence of an institutional and organizational structure supportive of the introduction and usage of biotechnological knowledge. The present contribution discusses this problem in its national, regional, and sectoral dimensions. By focusing on the biopharmaceutical sector, it is shown that the regulatory environment and the capital market constitute serious bottlenecks to further development. |
| Subjects: | | China health biotechnology innovation system pharmaceutical |
| Document Type: | | Working Paper |
| Appears in Collections: | | Duisburger Arbeitspapiere Ostasienwissenschaften, Universität Duisburg-Essen
|
| |
| | |
Download bibliographical data as:
BibTeX
|
| |
Share on:http://hdl.handle.net/10419/45003
|
Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.
|